We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jan 2023
  • Code : CMI103
  • Pages :177
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Negative pressure wound therapy (NPWT) systems are FDA class II devices that consist of a vacuum pump, drainage tubing, and wound dressing set requiring electricity to maintain its use. NPWT is indicated for the application of suction (negative pressure) to promote wound healing and for the removal of fluids such as wound exudate, irrigation fluids, bodily fluids, or infectious materials. NPWT may be indicated for use on chronic, acute, traumatic, sub-acute, and dehisced wounds, diabetic ulcers, pressure injuries, skin flaps, and grafts.

Global negative pressure wound therapy (NPWT) devices market is estimated to be valued at US$ 2,288.1 million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Figure 1. Global Negative Pressure Wound Therapy (NPWT) Devices Market Share (%), by Product Type, 2022

NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET

To learn more about this report, request a free sample copy

Global Negative Pressure Wound Therapy (NPWT) Devices Market- Drivers

Increasing prevalence of chronic wounds and ulcers among the global population is expected to drive the growth of the global negative pressure wound therapy (NPWT) devices market during the forecast period.

For instance, according to an article published in the National Library of Medicine, on October 5, 2020, titled “The Incidence of Pressure Ulcers and its Associations in Different Wards of the Hospital: A Systematic Review and Meta-Analysis,” it is estimated that about 2.5 million hospitalizations annually in the U.S. are due to pressure ulcers. Moreover, in the U. S., about US$ 11 billion is spent annually by the healthcare system for the prevention and treatment of pressure ulcers.

Increase in the prevalence of diabetes is expected to the drive the market growth over the forecast period.

For instance, according to the World Health Organization (WHO), as of September 16, 2022, 422 million people globally have diabetes, and the prevalence has been rising more rapidly in low- and middle-income countries than in high-income countries. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths, globally.

Negative Pressure Wound Therapy (NPWT) Devices Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 2,288.1 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.5% 2030 Value Projection: US$ 3,789.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Single-use NPWT Devices, Conventional NPWT Devices
  • By Application: Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burn Wounds, Others (Surgical Wounds, Traumatic Wounds, etc.)
  • By End User: Hospitals, Home Care Settings, Others (Ambulatory Surgery Centers (ASCs), Specialty Clinics, etc.)
Companies covered:

3M, Cardinal Health, Smith+Nephew, Genadyne, DeRoyal Industries, Inc., Medela AG, Convatec Inc., Mölnlycke Health Care AB, PAUL HARTMANN AG, ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, Cork Medical, LLC, and Devon Medical Products

Growth Drivers:
  • Increase in the prevalence of chronic wounds and ulcers 
  • Rise in the global burden of diabetes 
Restraints & Challenges:
  • Product recall and complications associated with NPWT devices

Figure 2. Global Negative Pressure Wound Therapy (NPWT) Devices Market Share (%), by Region, 2022

NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES MARKET

To learn more about this report, request a free sample copy

Global Negative Pressure Wound Therapy (NPWT) Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another. Pre-pandemic wound care model typically required visits to an outpatient facility (e.g., wound care center), which in response to the pandemic were misclassified as nonessential or limited access. Thus, negatively impacting negative pressure wound therapy devices market.

Global Negative Pressure Wound Therapy (NPWT) Devices Market: Key Developments

On October 13, 2022, 3M Health Care Medical Solutions, a division of 3M, announced that its 3M V.A.C. Therapy negative pressure wound therapy (NPWT) had surpassed a clinical evidence milestone of 2,000 published, peer-reviewed medical journal studies. V.A.C. Therapy is the first and only NPWT solution to garner this number of published studies about its therapy. It is backed by more clinical data than any other brand, accounting for more than 75% of published NPWT clinical evidence.

On August 24, 2021, Aatru Medical, LLC, a privately-held medical device company, announced that it had received the U.S. Food and Drug Administration (FDA) 510(k) Class II clearance for its NPSIMS Negative Pressure Surgical Incision Management System for the NPWT market.

Global Negative Pressure Wound Therapy (NPWT) Devices Market: Restraint

The major factors that hinder growth of the global negative pressure wound therapy (NPWT) devices market include product recall and complications caused due to NPWT devices. For instance, on December 2, 2021, the government of Canada announced the recall of Avelle Negative Pressure Wound Therapy Pump manufactured by Convatec Inc., a medical products and technologies company, due to the manufacturing defects.

Global Negative Pressure Wound Therapy (NPWT) Devices Market- Key Players

Major players operating in the global negative pressure wound therapy (NPWT) devices market include 3M, Cardinal Health, Smith+Nephew, Genadyne, DeRoyal Industries, Inc., Medela AG, Convatec Inc., Mölnlycke Health Care AB, PAUL HARTMANN AG, ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, Cork Medical, LLC, and Devon Medical Products

Frequently Asked Questions

Global negative pressure wound therapy (NPWT) devices market size is estimated to be valued at US$ 2,288.1 million in 2022 and is expected to exhibit a CAGR of 6.5% between 2022 and 2030.

Factors such as increase in the prevalence of chronic wounds and ulcer and rise in the global burden of diabetes are expected to drive the market.

Conventional NPWT devices is the leading product type segment in the market.

The major factors hampering growth of the market include product recall and complications associated with negative pressure wound therapy (NPWT) devices.

Major players operating in the market include 3M, Cardinal Health, Smith+Nephew, Genadyne, DeRoyal Industries, Inc., Medela AG, Convatec Inc., Mölnlycke Health Care AB, PAUL HARTMANN AG, ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, Cork Medical, LLC, and Devon Medical Products

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo